Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Diemberger

Showing results (61-70 of 238) with videos related to

Pageof 24
Sort By:
Expert Opinion on Pharmacotherapy|January 20, 2022
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fractionEmanuel Raschi, Igor Diemberger, Mario Sabatino, et al.
Heart (British Cardiac Society)|May 24, 2015
Holter ECG for pacemaker/defibrillator carriers: what is its role in the era of remote monitoring?Igor Diemberger, Beatrice Gardini, Cristian Martignani, et al.
Indian Heart Journal|February 27, 2014
Cost-effectiveness of implantable cardioverter-defibrillator in today's worldGiuseppe Boriani, Paolo Cimaglia, Mauro Biffi, et al.
Journal of Atrial Fibrillation|May 13, 2017
Atrial Fibrillation in Patients with Cardiac Resynchronization Therapy: Clinical Management and OutcomeGiuseppe Boriani, Paola Battistini, Igor Diemberger, et al.
Giornale Italiano Di Cardiologia (2006)|February 14, 2020
[ETNA-AF study: Italian baseline data and comparison with the European population in atrial fibrillation patients treated with edoxaban]Letizia Riva, Igor Diemberger, Giuseppe Di Pasquale, et al.
Current Heart Failure Reports|October 7, 2020
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and ProarrhythmiaMilo Gatti, Emanuel Raschi, Elisabetta Poluzzi, et al.
European Heart Journal|September 17, 2008
Atrial fibrillation ablation: beyond electro-mechanical mattersCristian Martignani, Igor Diemberger, Mauro Biffi, et al.
Pacing and Clinical Electrophysiology : PACE|March 17, 2010
Actual pacemaker longevity: the benefit of stimulation by automatic capture verificationMauro Biffi, Matteo Bertini, Davide Saporito, et al.
Journal of Medical Economics|October 7, 2020
Cost-effectiveness of cardiac resynchronization therapyCristian Martignani, Giulia Massaro, Igor Diemberger, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 12, 2025
Prospective evaluation of carbon dioxide as a contrast medium in pacemakers or defibrillators carriers for venous angiography (SPARKLING pilot study)Alberto Spadotto, Maria Carelli, Giulia Massaro, et al.
Pageof 24

Showing results (61-70 of 238) with videos related to

Sort By:
Pageof 24
Expert Opinion on Pharmacotherapy|January 20, 2022
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fractionEmanuel Raschi, Igor Diemberger, Mario Sabatino, et al.
Heart (British Cardiac Society)|May 24, 2015
Holter ECG for pacemaker/defibrillator carriers: what is its role in the era of remote monitoring?Igor Diemberger, Beatrice Gardini, Cristian Martignani, et al.
Indian Heart Journal|February 27, 2014
Cost-effectiveness of implantable cardioverter-defibrillator in today's worldGiuseppe Boriani, Paolo Cimaglia, Mauro Biffi, et al.
Journal of Atrial Fibrillation|May 13, 2017
Atrial Fibrillation in Patients with Cardiac Resynchronization Therapy: Clinical Management and OutcomeGiuseppe Boriani, Paola Battistini, Igor Diemberger, et al.
Giornale Italiano Di Cardiologia (2006)|February 14, 2020
[ETNA-AF study: Italian baseline data and comparison with the European population in atrial fibrillation patients treated with edoxaban]Letizia Riva, Igor Diemberger, Giuseppe Di Pasquale, et al.
Current Heart Failure Reports|October 7, 2020
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and ProarrhythmiaMilo Gatti, Emanuel Raschi, Elisabetta Poluzzi, et al.
European Heart Journal|September 17, 2008
Atrial fibrillation ablation: beyond electro-mechanical mattersCristian Martignani, Igor Diemberger, Mauro Biffi, et al.
Pacing and Clinical Electrophysiology : PACE|March 17, 2010
Actual pacemaker longevity: the benefit of stimulation by automatic capture verificationMauro Biffi, Matteo Bertini, Davide Saporito, et al.
Journal of Medical Economics|October 7, 2020
Cost-effectiveness of cardiac resynchronization therapyCristian Martignani, Giulia Massaro, Igor Diemberger, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 12, 2025
Prospective evaluation of carbon dioxide as a contrast medium in pacemakers or defibrillators carriers for venous angiography (SPARKLING pilot study)Alberto Spadotto, Maria Carelli, Giulia Massaro, et al.
Pageof 24